Search

PROCEPT BioRobotics Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

20.28 2.68

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

20.28

Max

21.21

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-1.8M

-32M

Pardavimai

6.7M

83M

Pelnas, tenkantis vienai akcijai

-0.56

Pelno marža

-38.058

Darbuotojai

888

EBITDA

-7.3M

-29M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+13.33% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-03

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-325M

1B

Ankstesnė atidarymo kaina

17.6

Ankstesnė uždarymo kaina

20.28

Naujienos nuotaikos

By Acuity

50%

50%

128 / 340 reitingas Healthcare

PROCEPT BioRobotics Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-07 20:02; UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

2026-08-06 20:03; UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

2026-08-05 19:52; UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

2026-08-04 23:02; UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

2026-08-03 20:03; UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

2026-07-31 20:02; UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

2026-07-30 19:58; UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

2026-07-29 16:26; UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

2026-07-28 19:26; UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

2026-07-27 17:02; UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

2026-07-22 19:41; UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

2026-07-21 16:01; UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

2026-07-20 19:56; UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Akcijų palyginimas

Kainos pokytis

PROCEPT BioRobotics Corp Prognozė

Kainos tikslas

By TipRanks

13.33% į viršų

12 mėnesių prognozė

Vidutinis 23.13 USD  13.33%

Aukščiausias 29 USD

Žemiausias 19 USD

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines PROCEPT BioRobotics Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

11 ratings

3

Pirkti

7

Laikyti

1

Parduoti

Rinkos nuotaikos

By Acuity

128 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat